Assistant Professor Of Surgery Associate Program Director General Surgery Residency
General Surgery
Dr. Farin Amersi, MD
|
|
Give Review
Farin Amersi is an expert in the field of General Surgery. He researched medicine at University of Pittsburgh School of Medicine. He over the years received 1 awards: "Fellow (FACS)". Farin Amersi is a published doctor as well. He has 53 publications published. The latest was: Effect of Breast Cancer After Ovarian Cancer on Mortality for BRCA Mutation Carriers-Reply. He accepts Medicare.
Publications
- Effect of Breast Cancer After Ovarian Cancer on Mortality for BRCA Mutation Carriers-Reply.
- Breast Cancer Following Ovarian Cancer in BRCA Mutation Carriers.
- Comparison of Nodal Metastasis Between BRCA Mutation Carriers and Non-BRCA Mutation Carriers with Breast Cancer.
- A Novel Surgical Approach for the Treatment of Severe Alkaline Reflux after Total Gastrectomy and Roux-en-Y Reconstruction.
- Management of the axilla.
- Small bowel carcinoid: Location isn't everything!
- Thromboprophylaxis and major oncologic surgery performed with epidural Analgesia.
- Postmastectomy radiation of latissimus dorsi myocutaneous flap reconstruction is well tolerated in women with breast Cancer.
- Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway.
- Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injury.
- Heme oxygenase 1 gene transfer prevents CD95/Fas ligand-mediated apoptosis and improves Liver allograft survival via carbon monoxide signaling pathway.
- Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat Livers from ischemia-reperfusion injury.
- CD154-CD40 T-cell costimulation pathway is required in the mechanism of hepatic ischemia/reperfusion injury, and its blockade facilitates and depends on heme oxygenase...
- Pretransplant model to predict posttransplant survival in Liver transplant patients.
- P-selectin glycoprotein ligand-1 (rPSGL-Ig)-mediated blockade of CD62 selectin molecules protects rat steatotic Liver grafts from ischemia/reperfusion injury.
- Upregulation of Bag-1 by ex vivo gene transfer protects rat Livers from ischemia/reperfusion injury.
- Donor and recipient outcomes in right lobe adult living donor Liver transplantation.
- Fibronectin-alpha 4 beta 1 integrin-mediated blockade protects genetically fat Zucker rat Livers from ischemia/reperfusion injury.
- Prevalence of metastases in hepatocellular Carcinoma: risk factors and impact on survival.
- Palliative care for colorectal Cancer.
- CD62 blockade with P-Selectin glycoprotein ligand-immunoglobulin fusion protein reduces ischemia-reperfusion injury after rat Intestinal transplantation.
- Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience.
- The benefits and limitations of sentinel lymph node biopsy.
- Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 Liver transplants.
- Prediction of Breast tumor progression by integrity of free circulating DNA in serum.
- Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy.
- The role of sentinel lymph node biopsy in the management of melanoma.
- Colorectal Cancer: epidemiology, risk factors, and health services.
- Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the Small intestine.
- Long-term survival after radiofrequency ablation of complex unresectable Liver tumors.
- Chemokine receptor CXCR4 expression in patients with melanoma and colorectal Cancer liver metastases and the association with disease outcome.
- Can axillary radiotherapy replace axillary dissection for early-stage breast Cancer?
- The clinical significance of MAGEA3 expression in pancreatic Cancer.
- FTY720 pretreatment reduces warm hepatic ischemia reperfusion injury through inhibition of T-lymphocyte infiltration.
- Heme oxygenase-1 gene transfer prevents CD95/FasL-mediated apoptosis and improves Liver allograft survival via carbon monoxide signaling pathway.
- FTY720: a novel approach to the treatment of hepatic ischemia-reperfusion injury.
- Heme oxygenase-1 overexpression protects rat Livers from ischemia/reperfusion injury with extended cold preservation.
- Improved survival through the reDuction of ischemia-reperfusion injury after rat intestinal transplantation using selective P-selectin blockade with P-selectin glycopr...
- Fifteen-year experience with adult and pediatric Liver transplantation at the University of California, Los Angeles.
- Upregulation of heme oxygenase-1 protects genetically fat Zucker rat Livers from ischemia/reperfusion injury.
- Predictors of survival after In vivo split liver transplantation: Analysis of 110 consecutive patients.
- Improved outcome after Intestinal transplantation: an 8-year, single-center experience.
- Advances in pediatric liver and Intestinal transplantation.
- A novel iron chelator in combination with a P-selectin antagonist prevents ischemia/reperfusion injury in a rat Liver model.
- Surgical advances in Liver transplantation. Living related and split donors.
- Allochimeric class I MHC inhibits chronic rejection in cardiac allografts.
- Amelioration of hepatic ischemia/reperfusion injury with intercellular adhesion molecule-1 antisense oligodeoxynucleotides.
- Factors determining outcome of liver transplantation for hepatocellular Carcinoma associated with hepatitis C cirrhosis.
- Technical challenges of hepatic venous outflow reconstruction in right lobe adult living donor Liver transplantation.
- Outcome after Intestinal transplantation: results from one center's 9-year experience; discussion 1031-2.
- Allochimeric class I MHC molecules prevent chronic rejection and attenuate alloantibody responses.
- Early graft function after pediatric liver transplantation: comparison between in Situ split liver grafts and living-related liver grafts.
Schools
University of Pittsburgh School of Medicine
Chas R Drew University Med And Science
Procedures Preformed
- Adrenalectomy
- Biopsy of Breast
- Breast Reconstruction
- Colectomy
- View All
Conditions Treated
- Abdominal Pain
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Appendicitis
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- CaliforniaCare HMO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Tiered Direct Access
- Select Plus HMO
- Access Plus Savenet
- Basic PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Covered California - Bronze PPO
- Employer Group HMO
- Health Net PPO
- Individual and Family PPO
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Heritage Signature
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Fellow (FACS)
Education
-
UCLA Medical Center -
University of Pittsburgh School of Medicine
Hospital
-
Cedars-Sinai Medical Center
Drug Facts
| NPI NUMBER | 1679587604 | |
| NPPES Provider LastName | AMERSI | |
| NPPES Provider FirstName | FARIN | |
| NPPES Provider ZIPCode | 900481804 | |
| NPPES Provider State | CA | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 248.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 35.0 | |
| Percent Opioid Claims | 14.11 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1679587604 |
| Last Name Of The Provider | AMERSI |
| First Name Of The Provider | FARIN |
| View All |
Similar Doctors
|
|
Dr. Mark Y. Choi, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. David P. Magner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neel R. Joshi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mossi S. Salibian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leo Gordon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary M. Tearston, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alagappan A. Annamalai, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Karen N. Zaghiyan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott R. Karlan, MD
This Doctor is OpenDoctor Recommended.
|